Scientific Library of Tomsk State University

   E-catalog        

Image from Google Jackets
Normal view MARC view

Noncolorectal, Nonneuroendocrine Liver Metastases electronic resource Diagnosis and Current Therapies / edited by Isidoro Di Carlo.

Contributor(s): Di Carlo, Isidoro [editor.] | SpringerLink (Online service)Material type: TextTextPublication details: Cham : Springer International Publishing : Imprint: Springer, 2015Description: XIII, 220 p. 21 illus., 13 illus. in color. online resourceContent type: text Media type: computer Carrier type: online resourceISBN: 9783319092935Subject(s): medicine | Endocrinology | Oncology | Neurosurgery | Surgery | Minimally Invasive Surgery | Surgical Oncology | Medicine & Public Health | Surgical Oncology | Minimally Invasive Surgery | Surgery | Oncology | Neurosurgery | EndocrinologyDDC classification: 616.994 LOC classification: RD651-678Online resources: Click here to access online
Contents:
Foreword -- Preface -- 1 Liver metastases from adrenocortical cancer -- 2 Liver metastases from brain cancer -- 3 Liver metastases from breast cancer -- 4 Liver metastases from kidney cancer -- 5 Liver metastases from larynx cancer -- 6 Liver metastases from lung cancer -- 7 Liver metastases from melanoma cancer -- 8 Liver metastases from ovarian and uterus cancer -- 9 Liver metastases from pancreas cancer -- 10 Liver metastases from salivar glands cancer -- 11 Liver metastases from sarcomas cancer -- 12 Liver metastases from stomach cancer -- 13 Liver metastases from testis cancer -- 14 Liver metastases from thyroid cancer -- 15 Liver metastases from ureteral, bladder and prostate cancer -- 16 Liver Metastases from Brain Cancer.
In: Springer eBooksSummary: This book offers a complete overview on noncolorectal nonneuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history, and diagnosis. NCRNNE metastases to the liver are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy, and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Foreword -- Preface -- 1 Liver metastases from adrenocortical cancer -- 2 Liver metastases from brain cancer -- 3 Liver metastases from breast cancer -- 4 Liver metastases from kidney cancer -- 5 Liver metastases from larynx cancer -- 6 Liver metastases from lung cancer -- 7 Liver metastases from melanoma cancer -- 8 Liver metastases from ovarian and uterus cancer -- 9 Liver metastases from pancreas cancer -- 10 Liver metastases from salivar glands cancer -- 11 Liver metastases from sarcomas cancer -- 12 Liver metastases from stomach cancer -- 13 Liver metastases from testis cancer -- 14 Liver metastases from thyroid cancer -- 15 Liver metastases from ureteral, bladder and prostate cancer -- 16 Liver Metastases from Brain Cancer.

This book offers a complete overview on noncolorectal nonneuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history, and diagnosis. NCRNNE metastases to the liver are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy, and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.

There are no comments on this title.

to post a comment.